Drug Pricing Suit Not Subject To Medicare Process, Appellants Tell 5th Circuit

(April 17, 2024, 1:40 PM EDT) -- SAN ANTONIO — The government holds a “constitutionally dubious” position in a challenge to the Medicare drug price negotiation law, and a federal judge erred in dismissing on the grounds that the claim is subject to the Medicare Act channeling provision, appellants tell the Fifth Circuit U.S. Court of Appeals in an appellant brief....